Literature DB >> 23635790

Steroids and osteoporosis: the quest for mechanisms.

Stavros C Manolagas1.   

Abstract

Advances made during the last 35 years have improved our understanding of the mechanisms of steroid hormone action on bone and how physiologic, pathologic, or iatrogenic changes in hormone levels can lead to increased fracture risk. Estrogens, androgens, and glucocorticoids alter the cellular composition of bone by regulating the supply and lifespan of osteoclasts and osteoblasts. Additionally, they influence the survival of osteocytes, long-lived cells that are entombed within the mineralized matrix and mediate the homeostatic adaptation of bone to mechanical forces. Altered redox balance is a proximal underlying mechanism of some of these effects, and sex steroid deficiency or glucocorticoid excess contributes to the aging of the skeleton.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23635790      PMCID: PMC3635743          DOI: 10.1172/JCI68062

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis.

Authors:  S C Manolagas
Journal:  Endocr Rev       Date:  2000-04       Impact factor: 19.871

2.  THE METABOLIC EFFECTS OF STEROID HORMONES IN OSTEOPOROSIS.

Authors:  E C Reifenstein; F Albright
Journal:  J Clin Invest       Date:  1947-01       Impact factor: 14.808

3.  Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.

Authors:  R S Weinstein; R L Jilka; A M Parfitt; S C Manolagas
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

4.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

Authors:  B S Komm; C M Terpening; D J Benz; K A Graeme; A Gallegos; M Korc; G L Greene; B W O'Malley; M R Haussler
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

5.  Oxidative stress stimulates apoptosis and activates NF-kappaB in osteoblastic cells via a PKCbeta/p66shc signaling cascade: counter regulation by estrogens or androgens.

Authors:  Maria Almeida; Li Han; Elena Ambrogini; Shoshana M Bartell; Stavros C Manolagas
Journal:  Mol Endocrinol       Date:  2010-08-04

Review 6.  For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases.

Authors:  Stavros C Manolagas; A Michael Parfitt
Journal:  Bone       Date:  2012-09-23       Impact factor: 4.398

7.  Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids.

Authors:  Robert S Weinstein; Jin-Ran Chen; Cara C Powers; Scott A Stewart; Reid D Landes; Teresita Bellido; Robert L Jilka; A Michael Parfitt; Stavros C Manolagas
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

8.  1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone.

Authors:  C D Tsoukas; D M Provvedini; S C Manolagas
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

9.  Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice.

Authors:  Robert S Weinstein; Chao Wan; Qinglan Liu; Ying Wang; Maria Almeida; Charles A O'Brien; Jeff Thostenson; Paula K Roberson; Adele L Boskey; Thomas L Clemens; Stavros C Manolagas
Journal:  Aging Cell       Date:  2009-12-28       Impact factor: 9.304

10.  1,25-dihydroxyvitamin D3 receptors in human leukocytes.

Authors:  D M Provvedini; C D Tsoukas; L J Deftos; S C Manolagas
Journal:  Science       Date:  1983-09-16       Impact factor: 47.728

View more
  24 in total

1.  Exploratory analysis of the potential relationship between urinary molybdenum and bone mineral density among adult men and women from NHANES 2007-2010.

Authors:  Ryan C Lewis; Lauren E Johns; John D Meeker
Journal:  Chemosphere       Date:  2016-09-16       Impact factor: 7.086

2.  A soluble bone morphogenetic protein type 1A receptor fusion protein treatment prevents glucocorticoid-Induced bone loss in mice.

Authors:  Qinghe Geng; Ke Heng; Jie Li; Shen Wang; Huabei Sun; Liangwei Sha; Yilong Guo; Xinfa Nie; Qingjun Wang; Lei Dai; Xianzhong Zhu; Jiujie Kang; Liwu Shao; Juan Zhai; Sheng Miao; Qiang Lin; Kaijin Guo; Jin Wang
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

3.  NADPH oxidase 4 limits bone mass by promoting osteoclastogenesis.

Authors:  Claudia Goettsch; Andrea Babelova; Olivia Trummer; Reinhold G Erben; Martina Rauner; Stefan Rammelt; Norbert Weissmann; Valeska Weinberger; Sebastian Benkhoff; Marian Kampschulte; Barbara Obermayer-Pietsch; Lorenz C Hofbauer; Ralf P Brandes; Katrin Schröder
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

Review 4.  Obesity: Friend or foe for osteoporosis.

Authors:  Sudhaa Sharma; Vishal R Tandon; Shagun Mahajan; Vivek Mahajan; Annil Mahajan
Journal:  J Midlife Health       Date:  2014-01

5.  Core level regulatory network of osteoblast as molecular mechanism for osteoporosis and treatment.

Authors:  Ruoshi Yuan; Shengfei Ma; Xiaomei Zhu; Jun Li; Yuhong Liang; Tao Liu; Yanxia Zhu; Bingbing Zhang; Shuang Tan; Huajie Guo; Shuguang Guan; Ping Ao; Guangqian Zhou
Journal:  Oncotarget       Date:  2016-01-26

Review 6.  Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management.

Authors:  Gong-bin Lan; Xu-biao Xie; Long-kai Peng; Lei Liu; Lei Song; He-long Dai
Journal:  Biomed Res Int       Date:  2015-11-15       Impact factor: 3.411

7.  Protective effect of VK2 on glucocorticoid-treated MC3T3-E1 cells.

Authors:  Yue-Lei Zhang; Jun-Hui Yin; Hao Ding; Wei Zhang; Chang-Qing Zhang; You-Shui Gao
Journal:  Int J Mol Med       Date:  2016-12-01       Impact factor: 4.101

8.  Urine and Serum Electrolytes and Biochemical Values Associated with Osteoporosis in Premenopausal and Postmenopausal Women: A Longitudinal and Cross-Sectional Study Using Korean Genome and Epidemiology Study (KoGES) Cohort.

Authors:  Hae-Sang Park; Ga-Young Kim; Jong-Ah Lo; Jin-Sun Kim; Shin-Young Ahn; Gang-Jee Ko; Young-Joo Kwon; Ji-Eun Kim
Journal:  J Clin Med       Date:  2021-05-17       Impact factor: 4.241

9.  Solanum nigrum Line inhibits osteoclast differentiation and suppresses bone mineral density reduction in the ovariectomy‑induced osteoporosis model.

Authors:  Jae-Hyun Kim; Hwajeong Shin; Minsun Kim; Sangwoo Kim; Kwangchan Song; Hyuk-Sang Jung; Youngjoo Sohn
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

Review 10.  Effects of estrogens and estrogenic disrupting compounds on fish mineralized tissues.

Authors:  Patricia I S Pinto; Maria D Estêvão; Deborah M Power
Journal:  Mar Drugs       Date:  2014-08-15       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.